Emlozin 25 mg (Tablet)

Unit Price: ৳ 40.00 (1 x 15: ৳ 600.00)
Strip Price: ৳ 600.00

Medicine Details

Category Details
Generic Empagliflozin
Company Team pharmaceuticals ltd
Also available as
Emlozin 10 mg tablet

Title

  • Emlozin 25 mg Tablet

Categories

  • Medicine
  • Diabetes management
  • Cardiovascular health

Description

  • Empagliflozin indicated for type 2 diabetes mellitus
  • Reduces risk of cardiovascular death
  • SGLT-2 inhibitor for improving glycemic control
  • Dosage: 10 mg once daily, may increase to 25 mg
  • Contraindicated in severe renal impairment and dialysis
  • Common side effects: urinary tract infections, dehydration, hypotension
  • Storage conditions: Below 30°C, protected from light and moisture

Dosage

  • 10 mg once daily
  • May increase to 25 mg

Administration

  • Taken in the morning
  • With or without food

Mode of Action

  • SGLT-2 inhibitor
  • Reduces renal absorption of glucose
  • Contributes to weight loss and reduced blood pressure

Indications

  • Improving glycemic control in adults with type 2 diabetes mellitus
  • Reducing risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease

Interaction

  • Diuretics: Increased urine volume
  • Insulin or Insulin Secretagogues: Increased risk for hypoglycemia
  • Positive Urine Glucose Test: Not recommended for monitoring glycemic control
  • Interference with 1,5-anhydroglucitol (1,5-AG) Assay: Not recommended for monitoring glycemic control

Contraindications

  • History of serious hypersensitivity reaction to Empagliflozin or its ingredients
  • Severe renal impairment
  • End-stage renal disease
  • Dialysis

Side Effects

  • Urinary tract infections
  • Dehydration
  • Hypotension
  • Weakness
  • Dizziness
  • Increased thirstiness

Pregnancy & Lactation

  • Use during pregnancy only if potential benefit justifies potential risk to fetus
  • Not recommended when breastfeeding

Precautions & Warnings

  • Assessment of renal function prior to initiation and periodically thereafter
  • Not initiated if eGFR less than 45 ml/min/1.73 m²

Overdose Effects

  • Supportive measures recommended
  • Hemodialysis not studied for removal

Therapeutic Class

  • Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors

Storage Conditions

  • Below 30°C
  • Protected from light and moisture

Chemical Structure

  • Molecular Formula: C23H27ClO7

Pregnancy warnings

    • Use during pregnancy:
      • Only if potential benefit justifies potential risk to fetus
    • Use during breastfeeding:
      • Not recommended

Commonly Asked Questions

    • What is Emlozin 25 mg Tablet?:
      • SGLT-2 inhibitor which reduces the reabsorption of glucose from kidney
    • What is Emlozin 25 mg Tablet used for?:
      • Improving glycemic control in adults
    • Pregnancy warnings:
      • May be unsafe to use during pregnancy
      • Unsafe to use during breastfeeding
    • Effect on kidney function:
      • Caution in patients with underlying kidney disease
    • Effect on liver function:
      • No dose adjustment needed for patients with mild to moderate liver disease
    • Quick Tips:
      • Used alone or with other diabetes medicines
      • May cause dehydration, hypoglycemia, genital fungal and/or urinary tract infections
      • Monitor blood sugar regularly
      • Inform doctor about specific symptoms
      • Stay hydrated

Related Brands